MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
2023: Top 20 Genomics Companies in the World
NeoGenomics, Inc (NASDAQ:NEO)
Organization & Developments: NeoGenomics
Parents
NeoGenomics, Inc (NASDAQ:NEO)
Children
*NeoGenomics
*NeoGenomics Inc (NEO) - PROVIDES LABORATORY TESTING SERVICES TO PATHOLOGISTS, ONCOLOGISTS, UROLOGISTS, HOSPITALS/OTHER LABORATORIES
*NeoGenomics is a high-complexity CLIA-certified clinical laboratory that specializes in cancer genetics diagnostic testing
2019: Is NeoGenomics (NEO) Outperforming Other Medical Stocks This Year?
2020: NeoGenomics: ~27% Upside Potential Is Under-Reflected, Market Is Unfairly Discounting Shares
2021: NeoGenomics: Well-Funded Cancer Diagnostics Play Needs To Execute On Ambitious Growth Plan
2022: NeoGenomics, Inc. 2022 Q3 - Results - Earnings Call Presentation_ seekingalpha.com
2022: NeoGenomics: Market Punishment Continues, But Looks Justified_seekingalpha.com
2022: NeoGenomics: Too Early To Celebrate_ seekingalpha.com
2022: NeoGenomics: What The Leadership Shuffle Means_ seekingalpha.com
2023: NeoGenomics: Short-Term Upsides Possible, Long-Term Not Supported By Economic Value (NASDAQ:NEO)
2024: NeoGenomics: Progress, But A New Uncertainty
Jumps
*Key People: NeoGenomics
Finance & Acquisitions: NeoGenomics